Legal Representation
Attorney
Steven A. Abreu
USPTO Deadlines
Next Deadline
180 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-01-05)
Due Date
January 05, 2026
Grace Period Ends
July 05, 2026
Application History
34 eventsDate | Code | Type | Description |
---|---|---|---|
Jan 5, 2025 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
Nov 1, 2024 | NA15 | E | SEC. 15 ACKNOWLEDGEMENT - E-MAILED |
Nov 1, 2024 | 15AK | O | REGISTERED - SEC. 15 ACKNOWLEDGED |
Nov 1, 2024 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Jul 22, 2024 | E15R | I | TEAS SECTION 15 RECEIVED |
Dec 23, 2022 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
Dec 23, 2022 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
Dec 23, 2022 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Jul 1, 2022 | ES8R | I | TEAS SECTION 8 RECEIVED |
Jan 5, 2021 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Nov 4, 2020 | CCON | T | COUNTERCLAIM OPP. NO. 999999 |
Feb 10, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Apr 27, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Apr 27, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Jan 5, 2016 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Nov 27, 2015 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
Aug 13, 2015 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
Jul 14, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jul 14, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jun 24, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jun 10, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Jun 10, 2015 | ALIE | A | ASSIGNED TO LIE |
May 20, 2015 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Apr 28, 2015 | DOCK | D | ASSIGNED TO EXAMINER |
Apr 8, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Apr 7, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Apr 7, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Nov 22, 2014 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Nov 22, 2014 | GNRT | F | NON-FINAL ACTION E-MAILED |
Nov 22, 2014 | CNRT | R | NON-FINAL ACTION WRITTEN |
Nov 15, 2014 | DOCK | D | ASSIGNED TO EXAMINER |
Aug 12, 2014 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Aug 11, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Aug 5, 2014 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Pharmaceutical research and development services, namely, research and development of pharmaceuticals to treat central nervous system disorders
First Use Anywhere:
20111000
First Use in Commerce:
20111000
Additional Information
Design Mark
The mark consists of the words "SAGE THERAPUTICS", to the left of which appears an image of a solid circle enclosed in a larger incomplete circle.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"